share_log

Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-K2 HealthVentures Equity Trust LLC(5.2%),Parag Shah(5.2%), etc.

SEC announcement ·  Feb 14 16:50
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more